Advancing Cancer Biology: Highlights from the 2025 FASEB SRC on Cellular Plasticity in Cancer

The inaugural FASEB Science Research Conference (SRC) on Cellular Plasticity in Cancer was held in May 2025 in Hong Kong SAR, China. This event brought together leading experts to discuss cutting-edge research centered on cancer cell plasticity. The conference featured comprehensive presentations covering a broad spectrum of topics, including oncofetal reprogramming in tumor development and progression, mechanisms regulating cancer cell plasticity, metabolic reprogramming and its role in tumor progression, cancer cell plasticity during metastasis, cancer stem cell programs within the tumor microenvironment, tumor plasticity and immune evasion, as well as innovative therapeutic strategies aimed at targeting stem cell-like states, modulating cancer cell states, and effectively controlling disease progression. It is anticipated that the insights gained from this meeting will catalyze further advancements in cancer biology and therapy.

• Publication year

  2025

• Venue

  Cancer heterogeneity and plasticity

• Publication date

  2025-10-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.47248/chp2502040018PMID 41221269PMCID 12599846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defining breast epithelial cell types in the single-cell era.

  2025cited by this paper
• Computational ranking identifies Plexin-B2 in circulating tumor cell clustering with monocytes in breast cancer metastasis

  2025cited by this paper
• AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models.

  2025cited by this paper
• Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypes

  2025cited by this paper
• Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics

  2025cited by this paper
• The multilayered transcriptional architecture of glioblastoma ecosystems

  2025cited by this paper
• Programs, origins and immunomodulatory functions of myeloid cells in glioma

  2025cited by this paper
• Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma

  2025cited by this paper
• Integrative multi-omics combined with functional pharmacological profiling in patient-derived organoids identifies personalized therapeutic vulnerabilities of adult high-grade gliomas

  2025cited by this paper
• Chimeric antigen receptor macrophages: a new frontier in hepatocellular carcinoma treatment

  2025cited by this paper
• SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer

  2025cited by this paper
• Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis

  2025cited by this paper
• Progressive plasticity during colorectal cancer metastasis

  2024cited by this paper
• SOX2 drives fetal reprogramming and reversible dormancy in colorectal cancer

  2024cited by this paper
• Integrin-activating Yersinia protein Invasin sustains long-term expansion of primary epithelial cells as 2D organoid sheets

  2024cited by this paper
• Pregnancy Reduces Il33+ Hybrid Progenitor Accumulation in the Aged Mammary Gland

  2024cited by this paper
• Androgen loss weakens anti-tumor immunity and accelerates brain tumor growth

  2024cited by this paper
• Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts

  2024cited by this paper
• A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast

  2024cited by this paper
• Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy

  2024cited by this paper
• Tuft cells act as regenerative stem cells in the human intestine

  2024cited by this paper
• Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells.

  2024cited by this paper
• Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer

  2023cited by this paper
• Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma

  2023cited by this paper
• SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma

  2023cited by this paper
• 1022 Sex-biased T cell exhaustion drives differential immune responses in glioblastoma

  2023cited by this paper
• Revealing de novo pyrimidine synthesis as a key vulnerability in brain tumors.

  2022cited by this paper
• Machine learning-assisted elucidation of CD81–CD44 interactions in promoting cancer stemness and extracellular vesicle integrity

  2022cited by this paper
• Hallmarks of Cancer: New Dimensions.

  2022cited by this paper
• Mitochondrial variant enrichment from high-throughput single-cell RNA sequencing resolves clonal populations

  2022cited by this paper
• Androgen receptor activity in T cells limits checkpoint blockade efficacy

  2022cited by this paper
• GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

  2022cited by this paper
• Oncofetal reprogramming in tumour development and progression

  2022cited by this paper
• Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma.

  2022cited by this paper
• Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma

  2021cited by this paper
• Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors

  2021cited by this paper
• CD8+ T cells inhibit metastasis and CXCL4 regulates its function

  2021cited by this paper
• Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing

  2021cited by this paper
• ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer

  2021cited by this paper
• Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression

  2021cited by this paper
• Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancer

  2021cited by this paper
• OUP accepted manuscript

  2021cited by this paper
• Understanding and targeting prostate cancer cell heterogeneity and plasticity

  2021cited by this paper
• Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner

  2020cited by this paper
• Hong Kong

  2020cited by this paper
• TMOD-08. PRIMARY AND RECURRENT GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS (PDOX) REPRESENT RELEVANT PATIENT AVATARS FOR PRECISION MEDICINE

  2020cited by this paper
• Transcriptional changes in the mammary gland during lactation revealed by single cell sequencing of cells from human milk

  2020cited by this paper
• Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer

  2020cited by this paper
• Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology

  2020cited by this paper
• Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma.

  2020cited by this paper
• Dietary Approaches to Cancer Therapy.

  2020cited by this paper
• Metabolic reprogramming and cancer progression

  2020cited by this paper
• Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment

  2019cited by this paper
• LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer

  2019cited by this paper
• Methionine is a metabolic dependency of tumor-initiating cells

  2019cited by this paper
• Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models.

  2018cited by this paper
• Females have the survival advantage in glioblastoma.

  2018cited by this paper
• MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes

  2017cited by this paper
• Differentiation dynamics of mammary epithelial cells revealed by single-cell RNA sequencing

  2017cited by this paper
• USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination

  2017cited by this paper
• Developing a Novel Two‐Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer

  2016cited by this paper
• Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer

  2016cited by this paper
• NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis

  2016cited by this paper
• EMT-induced metabolite signature identifies poor clinical outcome

  2015cited by this paper
• Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells

  2013cited by this paper
• Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes

  2013cited by this paper
• Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties

  2013cited by this paper
• Critical appraisal of the side population assay in stem cell and cancer stem cell research.

  2011cited by this paper
• Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

  2010cited by this paper
• Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

  2010cited by this paper
• Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Identification of stem cells in small intestine and colon by marker gene Lgr5

  2007cited by this paper
• Stem Cell Repor ts

  year unknowncited by this paper

• No citing papers are available for this paper.